Commissioner Robert Califf fielded questions from House appropriators about more than the Food and Drug Administration’s response to the infant formula shortage during a 19 May hearing on the FDA's fiscal year 2023 budget.
The use of hemp ingredients and kratom in dietary supplements and undisclosed fragrances in menstrual products also were covered in members’ questions in Califf’s first appearance before the Appropriations Committee’s...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?